Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details)

v2.4.1.9
Subsequent Events (Details) (Subsequent event, Actavis plc (formerly Forest Laboratories Holdings Limited), USD $)
In Millions, unless otherwise specified
1 Months Ended
Mar. 31, 2015
person
Subsequent event | Actavis plc (formerly Forest Laboratories Holdings Limited)
 
Subsequent events  
Payment received to fund expansion of clinical trial $ 10.0trvn_CollaborativeArrangementPaymentToFundExpansionOfClinicalTrial
/ us-gaap_CounterpartyNameAxis
= trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Number of patients before expansion of the trial 500trvn_NumberOfPatientsBeforeExpansionOfTrial
/ us-gaap_CounterpartyNameAxis
= trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember
Number of patients after expansion of the trial 620trvn_NumberOfPatientsAfterExpansionOfTrial
/ us-gaap_CounterpartyNameAxis
= trvn_ActavisFormerlyForestLaboratoriesHoldingsLimitedMember
/ us-gaap_SubsequentEventTypeAxis
= us-gaap_SubsequentEventMember